Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/14/2025

Target Heart Rate in Patients with Heart Failure and Atrial Fibrillation

Initial Heart Rate Targets

  • A lenient heart rate control strategy with a resting heart rate <110 beats per minute (bpm) should be considered as the initial target for patients with atrial fibrillation and heart failure, with stricter control reserved for those with continuing AF-related symptoms 1, 2
  • Lenient rate control (resting heart rate <110 bpm) is recommended as the initial approach for most patients with AF and heart failure 1, 2
  • The European Society of Cardiology recommends lenient rate control based on evidence from the RACE II trial, which showed that lenient rate control was non-inferior to strict rate control for clinical outcomes 1

When to Consider Stricter Rate Control

  • Stricter heart rate control should be considered in patients with ongoing symptoms despite lenient control, suspicion of tachycardia-induced cardiomyopathy, or significant exercise intolerance 1, 2, 3
  • The American College of Cardiology recommends stricter heart rate control targets, including a resting heart rate <80 bpm and a heart rate during moderate exercise <110 bpm 4

Medication Selection

  • For patients with left ventricular ejection fraction (LVEF) >40%, first-line options include beta-blockers, diltiazem, verapamil, and digoxin 1, 2
  • For patients with LVEF ≤40%, first-line options are more limited, including beta-blockers and digoxin, and non-dihydropyridine calcium channel blockers should be avoided 1, 2, 3, 5

Combination Therapy

  • The European Heart Society recommends considering combination therapy if a single drug does not adequately control heart rate or symptoms 1
  • Common combinations include beta-blocker plus digoxin, and for patients with heart failure with preserved ejection fraction (HFpEF), non-dihydropyridine calcium channel blocker plus digoxin 5

Advanced Options for Refractory Cases

  • For patients with inadequate rate control despite optimal medical therapy, AV nodal ablation with permanent pacemaker implantation or cardiac resynchronization therapy should be considered 1, 3

Acute Setting Management

  • For patients with AF, heart failure, and hemodynamic instability or severely depressed LVEF, intravenous amiodarone, digoxin, esmolol, or landiolol may be considered for acute rate control 1
  • The American College of Cardiology recommends electrical cardioversion in hemodynamically unstable patients 3

Monitoring Effectiveness

  • The American Heart Association recommends assessing heart rate control during both rest and exertion, and adjusting pharmacological treatment as necessary to keep ventricular rate within physiological range during activity 3
  • Consider 24-hour Holter monitoring to evaluate rate control throughout daily activities 6